US Stock MarketDetailed Quotes

THRD Third Harmonic Bio

Watchlist
  • 11.385
  • -0.405-3.44%
Trading Apr 16 12:18 ET
463.53MMarket Cap-14596P/E (TTM)

About Third Harmonic Bio Company

Third Harmonic Bio, Inc. develops pharmaceutical products for the treatment of allergic and immune diseases and disorders. It focuses on the development of the next wave of medicine for the treatment of allergic and inflammatory diseases. The company was founded on April 25, 2019 and is headquartered in San Francisco, CA.

Company Profile

SymbolTHRD
Company NameThird Harmonic Bio
Listing DateSep 15, 2022
Issue Price17.00
Founded2019
CEOMs. Natalie C. Holles
MarketNASDAQ
Employees30
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1700 Montgomery Street,Suite 210
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94111
Phone1-209-727-2457
Websitehttp://thirdharmonicbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Natalie C. Holles
  • Chief Executive Officer and Director
  • 9.92M
  • Christopher M. Murphy
  • Chief Financial and Business Officer
  • --
  • Dr. Edward R. Conner
  • Chief Medical Officer
  • 4.08M
  • Julie Person
  • Chief Administrative Officer
  • --
  • Mark T. Iwicki
  • Chairman of the Board
  • 441.54K
  • Robert J. Perez
  • Independent Director
  • 183.49K
  • Michael Gladstone
  • Independent Director
  • 182.77K
  • Thomas M. Soloway
  • Independent Director
  • 677.91K
  • Dr. H. Martin Seidel
  • Independent Director
  • 245.72K
  • Dr. David P. Bonita, M.D.
  • Independent Director
  • 182.77K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg